28th June 2016STORM Therapeutics raises £12 million series A funding to develop novel cancer therapeuticsSTORM Therapeutics, a spin-out company from the University of Cambridge’s Gurdon Institute focused on the identification and development of small molecule drugs that target RNA-modifying enzymes, has received...Read more